Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countries
Introduction: The high level of effectiveness of pneumococcal conjugate vaccines (PCVs) was demonstrated initially in high-income countries (HICs). However, because the burden of pneumococcal diseases (PDs) is greater in non-high-income countries (NHICs) than HICs, the assessment of these vaccines i...
Saved in:
Main Authors: | Robert Cohen (Author), Jérémie François Cohen (Author), Martin Chalumeau (Author), Corinne Levy (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
13-valent pneumococcal conjugate vaccine in Africa
by: Robert Cohen, et al.
Published: (2017) -
Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis media
by: Patricia Izurieta, et al.
Published: (2022) -
Investigation of Concurrent Pneumococcal Meningitis in Two Children Attending the Same Day-Care Center
by: Alexis Rybak, et al.
Published: (2022) -
Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness
by: Lee M Hampton, et al.
Published: (2012) -
How Are New Vaccines Prioritized in Low-Income Countries? A Case Study of Human Papilloma Virus Vaccine and Pneumococcal Conjugate Vaccine in Uganda
by: Lauren Wallace, et al.
Published: (2017)